Key Events This Week
Feb 23: Stock opens at Rs.397.15, down 1.59%
Feb 24: Technical deterioration noted; stock falls 2.20% to Rs.388.40
Feb 25: Hits 52-week and all-time lows near Rs.385; quarterly earnings reveal sharp profit declines
Feb 26: New 52-week low of Rs.375 recorded amid continued losses
Feb 27: Stock closes at fresh 52-week low of Rs.370.50, down 3.80%
Feb 23: Week Begins with a Sharp Decline Amid Broader Market Gains
Medi Assist Healthcare Services Ltd opened the week at Rs.397.15, down 1.59% from the previous close of Rs.403.55. This decline contrasted with the Sensex’s 0.39% gain to 36,817.86, highlighting early signs of relative weakness. The stock’s intraday range between Rs.395.40 and Rs.404.65 reflected selling pressure near its recent lows, setting the tone for the week’s bearish trend.
Feb 24: Technical Momentum Deteriorates as Stock Falls Further
The stock continued its downward trajectory, closing at Rs.388.40, a 2.20% drop. Technical analysis revealed a pronounced bearish momentum, with the Moving Average Convergence Divergence (MACD) indicator on the weekly timeframe signalling sustained downward pressure. The stock traded near its 52-week low of Rs.385.15, well below its 52-week high of Rs.594.40, underscoring the extent of the decline.
Despite the Sensex retreating 0.78% to 36,530.09, Medi Assist’s sharper fall reflected company-specific challenges amid a mixed insurance sector backdrop. The Relative Strength Index (RSI) remained neutral, indicating no immediate oversold bounce, while Bollinger Bands suggested increased volatility and bearish conditions.
Feb 25: Stock Hits 52-Week and All-Time Lows Amid Earnings Disappointment
On 25 February, Medi Assist’s stock plunged to a fresh 52-week low of Rs.384.1 and an all-time low of Rs.385.05, closing down 0.42%. This marked the fifth consecutive day of losses, cumulatively eroding 7.42% of value. The stock’s trading range narrowed, reflecting subdued intraday volatility despite the ongoing downtrend.
Quarterly financial results released for the December 2025 quarter revealed a 23.9% decline in profit before tax (PBT) to Rs.15.11 crores and a sharper 45.4% fall in net profit after tax (PAT) to Rs.11.11 crores compared to the previous four-quarter average. Interest expenses rose to a quarterly peak of Rs.8.39 crores, further pressuring margins.
These disappointing earnings contributed to the stock’s downgrade to a Strong Sell rating by MarketsMOJO, with a Mojo Score of 23.0. The stock traded below all key moving averages, reinforcing the bearish technical outlook amid a broader market that continued to advance modestly.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Feb 26: New 52-Week Low of Rs.375 Amid Continued Selling Pressure
The downtrend extended on 26 February as the stock recorded an intraday and closing low of Rs.375, marking a fresh 52-week and all-time low. This represented a 1.15% decline on the day and extended the losing streak to six consecutive sessions, with a cumulative loss of 7.88% over this period.
Despite the Sensex’s modest 0.19% decline, Medi Assist underperformed its sector by 0.7%, trading below all major moving averages. The company’s quarterly earnings and elevated interest expenses continued to weigh on sentiment, while the price-to-book ratio of 5 suggested a valuation premium not supported by recent financial performance.
Long-term fundamentals remain somewhat resilient, with a return on equity (ROE) of 14.05%, but this has not translated into positive price momentum. The Mojo Grade remained at Strong Sell, reflecting ongoing caution among investors.
Feb 27: Stock Closes at Rs.370.50, Marking a 7-Day Losing Streak
The week concluded with Medi Assist Healthcare Services Ltd’s stock closing at Rs.370.50, down 3.80% on the day and establishing a new 52-week and all-time low. This marked a seventh consecutive day of declines, with a cumulative loss of 10.36% over the period. The stock underperformed the Sensex’s 1.16% fall and its sector by nearly 3%.
Technical indicators remained firmly bearish, with the stock trading below all key moving averages and showing no signs of immediate support. Quarterly earnings continued to reflect pressure, with PBT and PAT down 23.9% and 45.4% respectively, and interest expenses at a record high.
Medi Assist Healthcare Services Ltd or something better? Our SwitchER feature analyzes this small-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Daily Price Performance Comparison
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-23 | Rs.397.15 | -1.59% | 36,817.86 | +0.39% |
| 2026-02-24 | Rs.388.40 | -2.20% | 36,530.09 | -0.78% |
| 2026-02-25 | Rs.386.75 | -0.42% | 36,679.75 | +0.41% |
| 2026-02-26 | Rs.385.15 | -0.41% | 36,748.49 | +0.19% |
| 2026-02-27 | Rs.370.50 | -3.80% | 36,322.56 | -1.16% |
Key Takeaways
Persistent Downtrend: Medi Assist’s stock declined steadily throughout the week, closing 8.19% lower, significantly underperforming the Sensex’s 0.96% fall. The seven-day losing streak highlights sustained selling pressure and weak investor sentiment.
Technical Weakness: The stock traded below all major moving averages and showed bearish signals across MACD, Bollinger Bands, and KST indicators. RSI remained neutral, suggesting no immediate oversold bounce.
Financial Challenges: Quarterly results revealed a 23.9% drop in PBT and a 45.4% decline in PAT, with interest expenses reaching a quarterly high of Rs.8.39 crores. These factors have weighed heavily on the stock’s valuation and momentum.
Valuation Concerns: Despite a price-to-book ratio of 5 indicating a premium valuation, the stock trades near all-time lows, reflecting market caution amid earnings weakness and sector headwinds.
Market Sentiment: The Mojo Score of 23.0 and Strong Sell rating underscore the cautious stance adopted by analysts and investors, with the stock’s underperformance extending over multiple time horizons.
Sector Context: Medi Assist’s decline contrasts with the broader insurance sector and Sensex, which have shown relative resilience, highlighting company-specific challenges.
Long-Term Fundamentals: The company maintains a solid ROE of 14.05%, suggesting operational strength despite short-term financial and market pressures.
Conclusion
Medi Assist Healthcare Services Ltd’s stock experienced a difficult week marked by sharp declines, multiple new lows, and deteriorating technical and fundamental indicators. The sustained downtrend reflects investor concerns over weakening profitability, elevated interest costs, and valuation pressures. While the company retains some long-term fundamental strength, the prevailing market sentiment remains cautious, as evidenced by the Strong Sell rating and continued underperformance relative to the Sensex and sector peers. Investors should closely monitor upcoming financial results and technical signals for any signs of stabilisation or recovery.
Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today
